1. Home
  2. MNRO vs DNA Comparison

MNRO vs DNA Comparison

Compare MNRO & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monro Inc.

MNRO

Monro Inc.

HOLD

Current Price

$12.04

Market Cap

545.6M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.89

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNRO
DNA
Founded
1957
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
545.6M
458.6M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MNRO
DNA
Price
$12.04
$7.89
Analyst Decision
Hold
Hold
Analyst Count
1
2
Target Price
$16.00
$8.50
AVG Volume (30 Days)
918.4K
1.1M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
6.69%
N/A
EPS Growth
113.64
46.49
EPS
0.03
N/A
Revenue
$1,157,176,000.00
$170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
$408.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.06
$5.37
52 Week High
$23.91
$17.58

Technical Indicators

Market Signals
Indicator
MNRO
DNA
Relative Strength Index (RSI) 39.99 56.64
Support Level $11.06 $7.16
Resistance Level $18.03 $9.82
Average True Range (ATR) 0.53 0.40
MACD 0.01 0.14
Stochastic Oscillator 2.49 73.46

Price Performance

Historical Comparison
MNRO
DNA

About MNRO Monro Inc.

Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: